Sponsor:
Saint John's Cancer Institute
Code:
NCT06794645
Conditions
Chordomas
Chordoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Pemetrexed Phase 2
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-19. This information was provided to ClinicalTrials.gov by Saint John's Cancer Institute on 2025-01-27.